Here is the second portfolio which, as with the first, managed to survive after eight weeks in a row of S&P gains; there are fewer positions here, but the key one, EFA, is quite large.
Adma Biologics crashed hard, but I think it has more to go. I’ve been tightening up the stop-loss along the way.
APA Corporation slipped nicely in recent days due to oil’s weakness.
I’m much more comfortable being short overseas equities than politically driven U.S. ones right now. What I like about EFA is that not only has it not achieved lifetime highs, but it has respected its price gap for months.
Humana has had a stunning rally in recent weeks, which made for a very appealing entry point with a stop-loss just above the dashed red line.
Schlumberger isn’t a great pattern, but this is merely a “double top” play, on the heels of its Iran-oil-rally price ascent.
